TITLE

Guidelines for the clinical management of familial adenomatous polyposis (FAP)

AUTHOR(S)
Vasen, H. F. A.; Mäslein, G.; Alonso, A.; Aretz, S.; Bernstein, I.; Bertario, L.; Blanco, I.; Bülow, S.; Burn, J.; Capella, G.; Colas, C.; Engel, C.; Frayling, I.; Friedl, W.; Hes, F. J.; Hodgson, S.; Järvinen, H.; Mecklin, J-P; M&3x00F8;ller, P.; Myrh&3x00F8;i, T.
PUB. DATE
May 2008
SOURCE
Gut;May2008, Vol. 57 Issue 5, p704
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND: Familial adenomatous polyposis (FAP) is a well-described inherited syndrome, which is responsible for <1% of all colorectal cancer (CRC) cases. The syndrome is characterised by the development of hundreds to thousands of adenomas in the colorectum. Almost all patients will develop CRC if they are not identified and treated at an early stage. The syndrome is inherited as an autosomal dominant trait and caused by mutations in the APC gene. Recently, a second gene has been identified that also gives rise to colonic adenomatous polyposis, although the phenotype is less severe than typical FAP. The gene is the MUTYH gene and the inheritance is autosomal recessive. In April 2006 and February 2007, a workshop was organised in Mallorca by European experts on hereditary gastrointestinal cancer aiming to establish guidelines for the clinical management of FAP and to initiate collaborative studies. Thirty-one experts from nine European countries participated in these workshops. Prior to the meeting, various participants examined the most important management issues according to the latest publications. A systematic literature search using Pubmed and reference lists of retrieved articles, and manual searches of relevant articles, was performed. During the workshop, all recommendations were discussed in detail. Because most of the studies that form the basis for the recommendations were descriptive and/or retrospective in nature, many of them were based on expert opinion. The guidelines described herein may be helpful in the appropriate management of FAP families. In order to improve the care of these families further, prospective controlled studies should be undertaken.
ACCESSION #
31931751

 

Related Articles

  • BRCA in breast cancer: ESMO Clinical Recommendations. Balmaña, J.; Díez, O.; Castiglione, M. // Annals of Oncology;May2009 Supplement 4, Vol. 20, piv19 

    The article presents clinical recommendations for diagnosis, treatment and follow-up of advanced colorectal cancer from the European Society for Medical Oncology (ESMO). The prevalence and penetrance of BRCA mutations and familial susceptibility to breast cancer are discussed. Information is...

  • New gene mutations in lung adenocarcinoma identified.  // Hem/Onc Today;11/25/2008, Vol. 9 Issue 21, p40 

    The article discusses research being done on lung cancer. It references a study published in the "Nature" journal. The study, conducted by research institutes, such as the Dana-Farber Cancer Institute and Broad Institute of Harvard, is about the 26 gene mutations identified in human lung...

  • Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade. Ding, SL; Sheu, LF; Yu, JC; Yang, TI; Chen, BF; Leu, FJ; Shen, CY // British Journal of Cancer;5/17/2004, Vol. 90 Issue 10, p1995 

    The role of the DNA double-strand-break (DSB) checkpoint/repair genes, ATM, BRCA1 and TP53, in sporadic breast cancer requires clarification, since ATM and BRCA1 mutations are rare in sporadic tumours. In an attempt to explain this phenomenon, we postulated that (i) in addition to genetic...

  • DNA bar code: screening methods of colorectal cancer. McCudden, Christopher; Willis, Monte S. // MLO: Medical Laboratory Observer;Nov2006, Vol. 38 Issue 11, p10 

    The article focuses on the use of DNA bar code screening methods for the detection of colorectal cancer. The majority of DNA tests detect either the loss of tumor-suppressor genes such as TP53 and acetylsalicylic acid phenacetin and caffeine or the activation of oncogenes such as K-ras. To...

  • Identificación de cáncer colorrectal hereditario: Síndrome de Lynch. Ñique-Carbajal, César; Sanchez-Renteria, Fernando; Wernhoff, Patrik; Dominguez-Valentin, Mev // Revista del Cuerpo Médico del Hospital Nacional Almanzor Aguina;2014, Vol. 7 Issue 1, p40 

    Lynch syndrome accounts for approximately 4% of all colorectal cancers. The syndrome follow an autosomal dominant pattern and predisposes individuals to cancer development early in life. Lynch syndrome is caused by mutations in the germline genes encoding proteins responsible for repairing the...

  • Assessing the value of CAN-gene mutations using MALDI-TOF MS. Kohler, Corina; Tavelin, Björn; Fan, Alex; Radpour, Ramin; Barekati, Zeinab; Levi, Fabio; Zhong, Xiao; Lenner, Per; Toniolo, Paolo // Journal of Cancer Research & Clinical Oncology;Aug2011, Vol. 137 Issue 8, p1239 

    Purpose: To identify cancer-linked genes, Sjöblom et al. and Wood et al. performed a genome-wide mutation screening in human breast and colorectal cancers. 140 CAN-genes were found in breast cancer, which in turn contained overall 334 mutations. These mutations could prove useful for...

  • Identification of Lynch Syndrome Among Patients With Colorectal Cancer. Moreira, Leticia; Balaguer, Francesc; Lindor, Noralane; de la Chapelle, Albert; Hampel, Heather; Aaltonen, Lauri A.; Hopper, John L.; Le Marchand, Loic; Gallinger, Steven; Newcomb, Polly A.; Haile, Robert; Thibodeau, Stephen N.; Gunawardena, Shanaka; Jenkins, Mark A.; Buchanan, Daniel D.; Potter, John D.; Baron, John A.; Ahnen, Dennis J.; Moreno, Victor; Andreu, Montserrat // JAMA: Journal of the American Medical Association;10/17/2012, Vol. 308 Issue 15, p1555 

    The article discusses a research for establishing an efficient strategy to identify Lynch Syndrome among the patients suffering from colorectal cancer (CRC). It informs that Lynch Syndrome is the most common form of hereditary CRC which is caused by germ line mutations in DNA mismatch repair...

  • Epidemiology and clinical findings of colorectal carcinoma in two tertiary care hospitals in Benghazi, Libya. Elzouki, Abdel-Naser; Habel, Salah; Alsoaeiti, Saeid; Abosedra, Adam; Khan, Fahmi // Avicenna Journal of Medicine;Oct2014, Vol. 4 Issue 4, p94 

    Aim: The aim is to determine the pattern of patients with colorectal cancer (CRC) seen in two tertiary hospitals in Benghazi, Libya. Materials and methods: The cohort includes all patients of CRC who were presented between January 2007 and December 2009 to the Oncology Department, Aljomhoria...

  • A blended knowledge translation initiative to improve colorectal cancer staging [ISRCTN56824239]. Wright, Frances C.; Law, Calvin HL.; Last, Linda D.; Klar, Neil; Ryan, David P.; Smith, Andrew J. // BMC Health Services Research;2006, Vol. 6, p4 

    Background: A significant gap has been documented between best practice and the actual practice of surgery. Our group identified that colorectal cancer staging in Ontario was suboptimal and subsequently developed a knowledge translation strategy using the principles of social marketing and the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics